Company / Cash & Equivalents
Healthpeak Properties Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$467.5M
FY2025
5-year range
$72.0M / $467.5M
FY2021-FY2025
Trend
+290.1%
vs FY2024
Sector context
#26 of 133
Real Estate
What the data says
Cash & Equivalents changed +290% YoY in FY2025, a notable deviation from the 9-year average annual change of +58%.
Based on SEC 10-K filings.
$467M in FY2025 with a 5-year CAGR of +60.3%. Top quartile in the Real Estate sector.
Improved from $118M to $467M over the past 2 years.
Real Estate sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +86.5%
- 5-Year CAGR
- +60.3%
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Real EstateTop 20% of 133This company $467.5M Sector average $334.0M
▼
+40.0% above sector average
Key checks
Key Insights
- Healthpeak Properties's cash & equivalents has grown for 3 consecutive years.
- 5-year CAGR of +60.3%, indicating consistent growth.
- In FY2025, cash & equivalents increased 290.1% year-over-year.
- Ranks #26 out of 133 companies in the Real Estate sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $467.5M | +290.1% |
| FY2024 | $119.8M | +1.9% |
| FY2023 | $117.6M | +63.3% |
| FY2022 | $72.0M | -54.5% |
| FY2021 | $158.3M | +257.9% |
| FY2020 | $44.2M | -45.0% |
| FY2019 | $80.4M | +48.9% |
| FY2018 | $54.0M | -2.4% |
| FY2017 | $55.3M | -41.6% |
| FY2016 | $94.7M | -72.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026